人工涙液 - 世界市場の考察、競合情勢、市場予測（2030年）

世界の人工涙液の市場規模は、2024年～2030年の予測期間にCAGRで5.1%の成長が見込まれます。人工涙液の需要は主に、慢性結膜炎、定期的な航空旅行、デジタルレイアウト、貧弱なまぶた、目の傷跡、食生活の乱れ、栄養失調、汚染レベルの急上昇、乾燥した天候、劇的な気候変動に長時間さらされることによるドライアイ症候群の増加によって後押しされています。さらに、防腐剤フリーの人工涙液に対する需要の増加、手術後のドライアイに対する先進のケアに対する要求の高まり、技術の進歩、携帯電話やスマートフォン中毒者の増加、コンタクトレンズを装用する人の増加、製品の発売や承認の増加などが、2024年～2030年の予測期間における人工涙液市場全体の成長に寄与しています。

人工涙液の市場力学

ドライアイ症候群の有病率の増加。利用可能な最新のデータによると、全世界で約3億4,400万人がドライアイ疾患（DED）に罹患しており、その数は若年層と老年層の両方で増加しているため、臨床医はドライアイ症を治療する最善の方法を見つけ出すことが急務となっています。人工涙液はドライアイに潤いと滑らかさを与え、目の外側の水分を維持することで、ドライアイを管理します。

さらに、スクリーンタイムが長くなると目の水分が不足しますが、人工涙液を使用することで管理することができます。米国疾病予防管理センター（CDC）の最新データによると、8～18歳の子供は、娯楽のために1日平均7.5時間もスクリーンの前で過ごし、そのうち4.5時間はテレビを見ています。1年間では、丸114日間もスクリーンの前で遊んでいることになります。このように、スクリーンタイムが長くなると、目の水分が不足し、ドライアイになります。

ドライアイ症候群に対する意識の高まりや、政府機関によるさまざまな取り組みも、人工涙液市場に大きな機会をもたらします。コンタクトレンズの需要の増加も人工涙液市場を促進すると予測されます。コンタクトレンズの使い過ぎは目の水分不足につながる可能性があるため、目の潤滑剤として使用される人工涙液のような製品の需要の増加につながります。

最後に、パイプラインに多くの製品が存在することも、今後数年間の市場成長にとって有利な機会を生み出します。例えば、2023年12月、Johnson & Johnson Vision Careは、コンタクトレンズを装着していない患者を対象に、Novelia® Eye Dropperに含まれるマルチドーズ防腐剤フリー潤滑目薬の評価を目的としたフェーズ2臨床試験を開始しました。この試験は2023年3月までに完了する予定です。

したがって、上記の要因が2024年～2030年の予測期間における人工涙液市場の成長に寄与しています。

しかし、製品に含まれる防腐剤に関連する汚染や副作用のリスク、代替の治療オプションの利用可能性などが人工涙液市場の成長を抑制する可能性があります。

人工涙液市場のセグメント分析

人工涙液市場の製品セグメントでは、ポリエチレングリコール・プロピレングリコールベース涙液のカテゴリが2023年に大きな収益シェアを獲得すると予測されます。これは、市場におけるポリエチレングリコール・プロピレングリコールベースの大型製品のプレゼンスや、このセグメントが提供する利点によるものと考えられます。

例えば、人工涙液は結膜印象細胞診を減少させ、角膜や結膜の染色を減少させ、涙液の分解時間を増加させます。また、天然涙液と同様の働きをし、目の乾燥による灼熱感や不快感を一時的に緩和します。また、これらの人工涙液は、眼表面の健康を改善し、ドライアイにおける扁平上皮形成によって引き起こされる変化を逆転させることができます。ポリエチレングリコール・プロピレングリコールベースの人工涙液が提供するこれらすべての利点は、色素眼症候群や眼感染症の治療に適した治療法となっています。

当レポートでは、世界の人工涙液市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 人工涙液市場レポートのイントロダクション

第2章 人工涙液市場のエグゼクティブサマリー

• 調査範囲
• 市場の概要
• 競合の評価

第3章 規制分析

• 米国
• 欧州
• 日本
• 中国

第4章 人工涙液市場の主な要因の分析

• 人工涙液市場の促進要因
• 人工涙液市場の抑制要因と課題
• 人工涙液市場の機会

第5章 人工涙液市場のポーターのファイブフォース分析

第6章 人工涙液市場に対するCOVID-19の影響分析

第7章 人工涙液市場のレイアウト

• 製品別
  • セルロース由来の涙液
  • グリセリン由来の涙液
  • ポリエチレングリコール・プロピレングリコールベースの涙液
  • その他
• デリバリー方法別
  • 目薬
  • 眼軟膏
• 用途別
  • ドライアイ疾患
  • アレルギー、感染症
• 地域
  • 北米の人工涙液の市場規模（2021年～2030年）
  • 欧州の人工涙液の市場規模（2021年～2030年）
  • アジア太平洋の人工涙液の市場規模（2021年～2030年）
  • その他の地域の人工涙液の市場規模（2021年～2030年）

第8章 人工涙液市場の企業と製品のプロファイル

• Santen Pharmaceutical Co., Ltd.
• Bausch & Lomb
• AbbVie
• Johnson & Johnson Vision Care
• Abbott
• Medicom Healthcare Ltd.
• Similasan Corporation
• URSAPHARM INDIA Pvt. Ltd
• Alcon Inc.
• Sun Pharmaceutical Industries, Inc.
• AFT Pharmaceuticals
• Hilco Vision
• Entod Research Cell UK Ltd.
• OASIS Medical, Inc.

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: COVID-19 Impact Analysis
• Table 3: Artificial Tears Market in Global (2021-2030)
• Table 4: Artificial Tears Market in Global by Product (2021-2030)
• Table 5: Artificial Tears Market in Global by Deliver Method (2021-2030)
• Table 6: Artificial Tears Market in Global by End-User (2021-2030)
• Table 7: Artificial Tears Market in Global by Geography (2021-2030)
• Table 8: Artificial Tears Market in North America (2021-2030)
• Table 9: Artificial Tears Market in North America by Country (2021-2030)
• Table 10: Artificial Tears Market in the US (2021-2030)
• Table 11: Artificial Tears Market in Canada (2021-2030)
• Table 12: Artificial Tears Market in Mexico (2021-2030)
• Table 13: Artificial Tears Market in Europe (2021-2030)
• Table 14: Artificial Tears Market in Europe by Country (2021-2030)
• Table 15: Artificial Tears Market in France (2021-2030)
• Table 16: Artificial Tears Market in Germany (2021-2030)
• Table 17: Artificial Tears Market in the United Kingdom (2021-2030)
• Table 18: Artificial Tears Market in Italy (2021-2030)
• Table 19: Artificial Tears Market in Spain (2021-2030)
• Table 20: Artificial Tears Market in the Rest of Europe (2021-2030)
• Table 21: Artificial Tears Market in Asia-Pacific (2021-2030)
• Table 22: Artificial Tears Market in Asia-Pacific by Country (2021-2030)
• Table 23: Artificial Tears Market in China (2021-2030)
• Table 24: Artificial Tears Market in Japan (2021-2030)
• Table 25: Artificial Tears Market in India (2021-2030)
• Table 26: Artificial Tears Market in Australia (2021-2030)
• Table 27: Artificial Tears Market in South Korea (2021-2030)
• Table 28: Artificial Tears Market in Rest of Asia-Pacific (2021-2030)
• Table 29: Artificial Tears Market in the Rest of the World (2021-2030)
• Table 30: Artificial Tears Market in RoW by Region (2021-2030)
• Table 31: Artificial Tears Market in the Middle East (2021-2030)
• Table 32: Artificial Tears Market in Africa (2021-2030)
• Table 33: Artificial Tears Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: COVID-19 Impact Analysis
• Figure 3: Artificial Tears Market in Global (2021-2030)
• Figure 4: Artificial Tears Market in Global by Product (2021-2030)
• Figure 5: Artificial Tears Market in Global by Delivery Method (2021-2030)
• Figure 6: Artificial Tears Market in Global by End-User (2021-2030)
• Figure 7: Artificial Tears Market in Global by Geography (2021-2030)
• Figure 8: Artificial Tears Market in North America (2021-2030)
• Figure 9: Artificial Tears Market in North America by Country (2021-2030)
• Figure 10: Artificial Tears Market in the US (2021-2030)
• Figure 11: Artificial Tears Market in Canada (2021-2030)
• Figure 12: Artificial Tears Market in Mexico (2021-2030)
• Figure 13: Artificial Tears Market in Europe (2021-2030)
• Figure 14: Artificial Tears Market in Europe by Country (2021-2030)
• Figure 15: Artificial Tears Market in France (2021-2030)
• Figure 16: Artificial Tears Market in Germany (2021-2030)
• Figure 17: Artificial Tears Market in the United Kingdom (2021-2030)
• Figure 18: Artificial Tears Market in Italy (2021-2030)
• Figure 19: Artificial Tears Market in Spain (2021-2030)
• Figure 20: Artificial Tears Market in the Rest of Europe (2021-2030)
• Figure 21: Artificial Tears Market in Asia-Pacific (2021-2030)
• Figure 22: Artificial Tears Market in Asia-Pacific by Country (2021-2030)
• Figure 23: Artificial Tears Market in China (2021-2030)
• Figure 24: Artificial Tears Market in Japan (2021-2030)
• Figure 25: Artificial Tears Market in India (2021-2030)
• Figure 26: Artificial Tears Market in Australia (2021-2030)
• Figure 27: Artificial Tears Market in South Korea (2021-2030)
• Figure 28: Artificial Tears Market in Rest of Asia-Pacific (2021-2030)
• Figure 29: Artificial Tears Market in the Rest of the World (2021-2030)
• Figure 30: Artificial Tears Market in RoW by Region (2021-2030)
• Figure 31: Artificial Tears Market in the Middle East (2021-2030)
• Figure 32: Artificial Tears Market in Africa (2021-2030)
• Figure 33: Artificial Tears Market in South America (2021-2030)
• Figure 34: Market Drivers
• Figure 35: Market Barriers
• Figure 36: Marker Opportunities
• Figure 37: PORTER'S Five Force Analysis

Artificial Tears Market By Product (Cellulose-Derived Tears, Glycerin-Derived Tears, Polyethylene Glycol And Propylene Glycol-Based Tears, And Others), By Delivery Method (Eye Drops And Eye Ointments), By Application (Dry Eye Disease, Allergies And Infections, And Others), and by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence dry eyes syndrome and increasing availability of over the counter (otc) artificial tears

The global artificial tears market is estimated to grow at a CAGR of 5.1% during the forecast period from 2024 to 2030. The demand for artificial tears is primarily being boosted by the increasing figures of dry eye syndrome due to prolonged exposure to chronic conjunctivitis, regular air travel, digital layouts, poor eyelid, scars of eye injury, poor diet, malnutrition, the surge in level of pollution, dry weather spells, and drastic climatic changes. Further, the increasing demand for preservative-free artificial tears, the growing requirement for advanced care for post-surgery dry eyes, technological advances, the mounting number of mobile and smartphone addicts, the escalating number of people wearing contact lenses, and the increasing product launches and approval among others are thereby contributing to the overall growth of the artificial tears market during the forecast period from 2024-2030.

Artificial Tears Market Dynamics:

The increase in the prevalence of dry eye syndrome. According to the latest data available, nearly 344 million people worldwide had dry eye disease (DED), and that number is growing in both young and old adults, making it imperative that clinicians figure out how best to treat it. Artificial tears provide moisture and lubrication to the dry eye and help to maintain moisture on the outer surface of the eyes, thereby managing dry eye disease.

Furthermore, increasing screen time will lead to a lack of moisture in the eyes, which can be managed by using artificial tears. The latest data provided by the Center for Disease Control and Prevention (CDC) stated that kids ages 8-18 spend, on average, spent a whopping 7.5 hours in front of a screen for entertainment each day, 4.5 of which are spent watching TV. Over a year, that adds up to 114 full days watching a screen for fun. Thus, increasing screen time will lead to a lack of moisture in the eyes and dry eyes which can be treated by lubricating eye drops or artificial tears.

The increasing awareness about dry eye syndrome and various other initiatives by government bodies will also generate significant opportunities for the artificial tear market. The increasing demand for contact lenses is also expected to propel the market of artificial tears as the over-usage of contact lenses may lead to the lack of moisture in the eyes and thereby leading to an increased demand for products such as artificial tears which are used as a lubricating agent for the eyes.

Lastly, the presence of a large of products in the pipeline will also create a lucrative opportunity for market growth during the upcoming years. For instance, in December 2023, Johnson & Johnson Vision Care, started a phase II clinical trial for the evaluation of multidose preservative-free lubricating eye drops contained in Novelia® Eye Dropper in non-contact lens-wearing patients. The study is estimated to get completed by March 2023.

Therefore, the above-mentioned factors are contributing to the growth of the Artificial Tears market during the forecast period from 2024-2030.

However, the risk of contamination and adverse reactions associated with preservatives present in the product, the availability of alternative treatment options, and others may restrict the artificial tears market growth.

Artificial Tears Market Segment Analysis:

Artificial Tears Market by Product (Cellulose Derived Tears, Glycerin Derived Tears, Polyethylene Glycol and Propylene Glycol-Based Tears, and Others), Delivery Method (Eye Drops and Eye Ointments), Application (Dry Eye Disease, Allergies and Infections, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the artificial tears market, the polyethylene glycol and propylene glycol-based tears category is expected to amass significant revenue share in the year 2023. This can be ascribed to the presence of large products based on polyethylene glycol and propylene glycol in the market and the advantages offered by the segment.

For instance, artificial tears decrease the conjunctival impression cytology, reduce corneal or conjunctival staining, and increase tear film break-up time. Also, they work similarly to natural tears and provide temporary relief from burning and discomfort due to dryness of the eye. Also, these artificial tears can improve ocular surface health and reverse the changes induced by squamous metaplasia in dry eye disease. All these advantages offered by the polyethylene glycol and propylene glycol-based artificial tears make it an apt treatment for treating dye eye syndrome and eye infections.

The increasing product launches and approvals will also certainly impact the demand for polyethylene glycol and propylene glycol-based artificial tears. For instance, in April 2022 Alcon, announced the launch of Systane Hydration Multi-Dose Preservative-Free Lubricant eye drops in the U.S. region. This product is a new addition to their existing portfolio of dry eye products. These new eye drops are made up of polyethylene glycol 400 (0.4%) and propylene glycol (0.3%). The eye drop is preservative-free and provides moisture to patients with sensitive dry eyes.

Therefore, the advantages offered by polyethylene glycol and propylene glycol-based artificial tears are predicted to contribute to the increasing demand for this product type thereby driving the growth of the overall artificial tears market during the forecast period.

North America is expected to dominate the overall Artificial Tears Market:

Among all the regions, North America is estimated to account for the largest share of the artificial tears market in the year 2023. Owing to the significance of key growth factors such as the rising prevalence of dry eye disease and eye infections will positively impact the North American artificial tears market. In addition, the increasing exposure to blue light from digital displays, enhanced use of mobile phones, raised pollution levels, and dry weather spells will increase the demand for artificial tears during the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about ophthalmic diseases also helped the market growth in this region.

As per the latest data available, between 16 million and 49 million Americans had dry eyes. This is between 5-15% of the total population. Also, twice as many women had been diagnosed as men. The increasing burden of dry eye disease will increase the demand for artificial tears as these eye drops will lubricate the eyes during the disease and will provide relief from dry eyes.

Additionally, the rising penetration of smartphones and tablets, demand for artificial tears during post-operative care, and technological advancements are some of the driving factors contributing to the market growth.

Coupled with the factors mentioned above, strategic activities such as product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in July 2022, Bausch+Lomb, a subsidiary of Bausch Health Companies Inc. announced the launch of Biotrue Hydration Boost Lubricant Eye Drops and Biotrue Micellar Eyelids Cleansing Wipes in the US region. These products are developed for patients suffering from irritated, dry eyes.

Also, in May 2022, Alcon, announced an agreement to acquire EYSUVIS® (loteprednol etabonate suspension) 0.25% pharmaceutical eye drops from Kala Pharmaceuticals, Inc. EYSUVIS will complement the Systane® family of eye drops (artificial tear) which includes the recently launched Systane Preservative-Free formulations now available in a convenient, multi-dose bottle. Thus, such strategic steps help to increase the demand for artificial tears, thereby driving the North America artificial tears market forward during the forecast period.

Artificial Tears Market Key Players:

Some of the key market players operating in the artificial tears market include Santen Pharmaceutical Co., Ltd., Bausch & Lomb, AbbVie, Johnson & Johnson Vision Care, Abbott, Medicom Healthcare Ltd., Similasan Corporation, URSAPHARM INDIA Pvt. Ltd, Alcon Inc., Sun Pharmaceutical Industries, Inc., AFT Pharmaceuticals, Akorn Operating Company LLC, Hilco Vision, Entod Research Cell UK Ltd., OASIS Medical, Inc., and others.

Recent Developmental Activities in the Artificial Tears Market:

In January 2022, Alcon announced the European launch of the newest addition to its innovative portfolio of dry eye products, Systane Complete Preservative-Free Lubricant Eye Drops, now in an easy-to-use, multi-dose bottle. Systane is the leading global artificial tear brand.

In February 2020, I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, launched its newest, most advanced addition to its I-DROP artificial tear line, called I-DROP®MGD.

In October 2019, Allergan plc launched three new over-the-counter (OTC) REFRESH RELIEVA products: REFRESH RELIEVA, REFRESH RELIEVA PF (preservative-free) multidose, and REFRESH RELIEVA for contacts. This new line of artificial tear formulations available in preserved, preservative-free multidose, and a formula designed for contact lens wearers, are specially formulated to relieve discomfort due to eye dryness and to prevent further irritation.

Key Takeaways from the Artificial Tears Market Report Study

Market size analysis for current artificial tears market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the artificial tears market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global artificial tears market.

Various opportunities available for the other competitor in the artificial tears market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current artificial tears market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for artificial tears market growth in the coming future?

Target Audience who can be benefited from this Artificial Tears Market Report Study

Artificial tears products providers

Research organizations and consulting companies

Artificial tears-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in artificial tears

Various End-users who want to know more about the artificial tears market and the latest technological developments in the artificial tears market.

Frequently Asked Questions for the Artificial Tears Market:

1. What are artificial tears?

Artificial tears are mentioned as lubricant eye drops that are applied for treating irritation and dryness against the deficiency in tear generation in dry eyes or keratoconjunctivitis sicca. These artificial tears are also applied for moistening contact lenses and during eye check-ups and inspections. These artificial tears are made by engaging water, salts, and polymers together

2. What is the market for global artificial tears?

The global artificial tears market is estimated to grow at a CAGR of 5.1% during the forecast period from 2024 to 2030.

3. What are the drivers for the global artificial tears market?

The demand for artificial tears is primarily being heightened by the increasing prevalence of dry eyes and eye allergies and infections. In addition, the advancement in artificial tears that aid in improving its efficacy and safety, increasing product launches and approvals, among others, thereby contribute to the overall growth of the artificial tears market during the forecast period from 2024-2030.

4. Who are the key players operating in the global artificial tears market?

Some of the key market players operating in the artificial tears market include Santen Pharmaceutical Co., Ltd., Bausch & Lomb, AbbVie, Johnson & Johnson Vision Care, Abbott, Medicom Healthcare Ltd., Similasan Corporation, URSAPHARM INDIA Pvt. Ltd, Alcon Inc., Sun Pharmaceutical Industries, Inc., AFT Pharmaceuticals, Akorn Operating Company LLC, Hilco Vision, Entod Research Cell UK Ltd., OASIS Medical, Inc., and others.

5. Which region has the highest share in the artificial tears market?

North America is expected to dominate the overall artificial tears market during the forecast period from 2024-2030. Factors such as the rising prevalence of dry eye disease and eye infections will positively impact the North American artificial tears market. In addition, the increasing exposure to blue light from digital displays, enhanced use of mobile phones, raised pollution levels, and dry weather spells will increase the demand for artificial tears during the forecast period. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about ophthalmic diseases also helped the market growth in this region.

Table of Contents

1.Artificial Tears Market Report Introduction

2. Artificial Tears Market Executive Summary

• 2.1. Scope of the Study
• 2.2. Market at Glance
• 2.3. Competitive Assessment

3. Regulatory Analysis

• 3.1. The United States
• 3.2. Europe
• 3.3. Japan
• 3.4. China

4. Artificial Tears Market Key Factors Analysis

• 4.1. Artificial Tears Market Drivers
  • 4.1.1. Rising prevalence of dry eyes and eye infections across the globe
  • 4.1.2. Increasing availability of over-the-counter (OTC) products
  • 4.1.3. Increased exposure to blue light from digital displays, enhanced use of mobile phones, raised pollution levels, and dry weather spells
• 4.2. Artificial Tears Market Restraints and Challenges
  • 4.2.1. Risk of contamination and adverse reactions associated with preservatives present in the product
  • 4.2.2. Availability of alternative treatment options
• 4.3. Artificial Tears Market Opportunities
  • 4.3.1. Presence of a robust number of artificial tears in the pipeline

5. Artificial Tears Market Porter's Five Forces Analysis

• 5.1. Bargaining Power of Suppliers
• 5.2. Bargaining Power of Consumers
• 5.3. Threat of New Entrants
• 5.4. Threat of Substitutes
• 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Artificial Tears Market

7. Artificial Tears Market Layout

• 7.1. By Product
  • 7.1.1. Cellulose Derived Tears
  • 7.1.2. Glycerin Derived Tears
  • 7.1.3. Polyethylene Glycol and Propylene Glycol-Based Tears
  • 7.1.4. Others
• 7.2. By Delivery Method
  • 7.2.1. Eye Drops
  • 7.2.2. Eye Ointments
• 7.3. By Application
  • 7.3.1. Dry Eye Disease
  • 7.3.2. Allergies and Infections
  • 7.3.3. Others
• 7.4. By Geography
  • 7.4.1. North America Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.1.1. United States Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.1.2. Canada Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.1.3. Mexico Artificial Tears Market Size in USD million (2021-2030)
  • 7.4.2. Europe Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.2.1. France Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.2.2. Germany Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.2.3. United Kingdom Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.2.4. Italy Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.2.5. Spain Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.2.6. Rest of Europe Artificial Tears Market Size in USD million (2021-2030)
  • 7.4.3. Asia-Pacific Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.3.1. China Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.3.2. Japan Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.3.3. India Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.3.4. Australia Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.3.5. South Korea Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.3.6. Rest of the Asia-Pacific Artificial Tears Market Size in USD million (2021-2030)
  • 7.4.4. Rest of the World (RoW) Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.4.1. Middle East Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.4.2. Africa Artificial Tears Market Size in USD million (2021-2030)
    • 7.4.4.3. South America Artificial Tears Market Size in USD million (2021-2030)

8. Artificial Tears Market Company and Product Profiles

• 8.1. Santen Pharmaceutical Co., Ltd.
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Bausch & Lomb
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. AbbVie
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. Johnson & Johnson Vision Care
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. Abbott
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Medicom Healthcare Ltd.
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Similasan Corporation
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. URSAPHARM INDIA Pvt. Ltd
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. Alcon Inc.
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Sun Pharmaceutical Industries, Inc.
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. AFT Pharmaceuticals
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Akorn Operating Company LLC
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Hilco Vision
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. Entod Research Cell UK Ltd.
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. OASIS Medical, Inc.
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us